Cincinnati Eye Institute, an EyeCare Partners Practice, Opens New CEI Retina Clinic at The Landings in Blue Ash

CINCINNATI--(BUSINESS WIRE)--EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, today announced the grand opening of its Cincinnati Eye Institute (CEI) Retina Clinic at The Landings in Blue Ash, furthering its commitment to providing the highest quality eye care.
Located at 9997 Carver Road, Level 2, in Blue Ash, this new state-of-the-art 36,000-square-foot clinical space is CEI’s 16th office in the greater Cincinnati area.
“As demand for quality eye care continues to rise, we at CEI are ready to meet this challenge through growth and expansion, so our greater Cincinnati area patients continue to enjoy access to world-class eye services right in their own backyard,” said James Osher, M.D., a third-generation Cincinnati ophthalmologist and Ohio Division Medical Director for EyeCare Partners.
“What makes this office so special is its singular focus on medical and surgical treatment of the retina,” added Osher. “The office is unique with state-of-the-art retina equipment, including the most advanced retina imaging platforms available. We will also be able to expand our bustling clinical trial and research services. This allows more patients the opportunity to participate in cutting-edge therapies.”
The new CEI Retina Clinic supports the expansion of CEI’s clinical trial capabilities, allowing patients access to investigational medical and surgical care. Currently, CEI has 28 active retina clinical trials.
“At CEI, we are focused on enhancing vision, advancing eye care and improving lives. The new CEI Retina Clinic advances our mission with world-class specialists working with the latest technology in a patient-friendly space,” said Daniel M. Miller, M.D., Ph.D., Ophthalmology Division President and Executive Medical Officer, EyeCare Partners. “CEI is also pioneering the future of eye care through our robust clinical trial programs in the Cincinnati area, and this space will help advance the future of retina care broadly.”
Retinal diseases currently impact more than 10 million Americans. These diseases affect the retina, the light-sensitive tissue located in the back of the eye. Common retinal diseases include diabetic retinopathy, macular degeneration, retinal tears and detachments, macular holes and retinitis pigmentosa. Retinal diseases can cause symptoms that impact vision, such as blindness or low vision. The most common causes of retinal damage include genetic and environmental factors, and these can be related to old age, light damage or trauma.
EyeCare Partners is the nation’s leading provider of clinically integrated eye care. Our national network of over 300 ophthalmologists and 700 optometrists provides a lifetime of care to our patients with a mission to enhance vision, advance eye care and improve lives. Based in St. Louis, Missouri, over 700 ECP-affiliated practice locations provide services that span the eye care continuum in 18 states and 30 markets. For more information, visit www.eyecare-partners.com, and follow us on LinkedIn.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.